ACHE and Alzheimer disease: Recent studies have indicated that the efficacy of clinically used acetylcholinesterase inhibitors, AChEIs (donepezil, rivastigmine, and galantamine), in the management of AD has been less than optimal, mild, and may not be clinically significant [39,40].